Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

BHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more

Markets Defused aims to present an easy-to-understand and straightforward recap of the week’s most engaging stock market news BHP takeover approach…

Pharma Stock Roundup: MRK, SNY, AZN, NVS Q1 Results, Pipeline & Regulatory Updates

Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.…

Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron

The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly…

AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript

AZN earnings call for the period ending March 31, 2024.…

AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript

…

FIVE at FIVE: FTSE 100 retreats; AstraZeneca and Barclays impress; BHP eyes Anglo American; Meta sheds billions

1. FTSE 100 closes at fresh record high FTSE 100 closed at a new record high of 8,078.86 after it…

BHP Targets Rival Anglo American, Meta Earnings Spook Investors | Bloomberg Markets Today 04/25/2024

Mining giant BHP approaches rival Anglo American with a takeover offer in a move that could spark the biggest shakeup…

AstraZeneca zu alter Stärke erwacht! Pharma-Champion erfolgreich in das neue Jahr gestartet - Aktienanalyse

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

Astrazeneca: Europäischer Pharma-Champion begeistert

Ein massiver Rückgang des Geschäfts mit Corona-Impfstoffen hatte bei vielen Pharmaaktien in der Vergangenheit zu Kursrückgängen geführt, so auch bei…

JEFFERIES stuft ASTRAZENECA auf Hold

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Astrazeneca nach Quartalszahlen auf "Hold" mit einem Kursziel von 11000 Pence…

Non-Hodgkin Lymphoma Pipeline Landscape 2024: Analysis of Over 220 Potential Pharmaceuticals in Development

Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma - Pipeline Insight, 2024" report has been added…

Astrazeneca: Zahlen treiben Aktie an

AstraZeneca meldete trotz Rückgangs bei Corona-Medikamenten starke Q1-Ergebnisse.…

AstraZeneca shares jump on much stronger Q1 top and bottom line By Investing.com

AstraZeneca shares jump on much stronger Q1 top and bottom line…

FTSE 100 Live: Index hits record; Anglo American jumps on BHP bid

FTSE 100 up 53 points to 8,093 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays rise 11.45am AstraZeneca strips…

FTSE 100 Live: Stocks bounce higher, BHP swoops for Anglo American, Barclays and AstraZeneca lead results day

FTSE 100 up 32 points to 8,072 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays lead risers 8.28am: Stocks…

FTSE 100 Live: Stocks steady, AstraZeneca, LSEG, Unilever and Barclays lead big update day

7.09am: FTSE 100 seen flat in pre market Futures contracts have the footsie opening a couple of points lower at…

FTSE 100 Live: Stocks steady, BHP swoops for Anglo American, Barclays and AstraZeneca lead results day

8.10am: Anglo receives ‘unsolicited’ cash offer from BHP Anglo American PLC (LSE:AAL) has confirmed a shock bid approach from BHP…

FTSE 100 Live: Index at record; Anglo American soars on BHP bid; Barclays, AstraZeneca up

FTSE 100 up 51 points to 8,092 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays rise 9.30am: Sainsbury’s non-food exposure…

AstraZeneca beats first-quarter revenue, profit estimates

AstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by resilient demand for its oncology and rare…

AstraZeneca beats first-quarter revenue, profit estimates By Reuters

AstraZeneca beats first-quarter revenue, profit estimates…

1st Quarter Results

AstraZeneca 25 April 2024 Q1 2024 results Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery Revenue and…

Ihre wichtigsten Termine: Frische Q1-Zahlen von: Alphabet, Snap, Intel, AstraZeneca, Hermes und Nestle

AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up

AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease…

Day ahead: Sainsburys, Barclays, AstraZeneca

AstraZenecas CEOs pay has been the subject of much debate recently. See if Pascal Soriot is justifying his £18.7 million…

Britain’s Magnificent 7: Do Rolls-Royce, AstraZeneca and Unilever make the cut?

The Magnificent 7 will be hogging US financial news headlines over the coming weeks. Not to be confused with the…

ANGLE shares jump 30% on AstraZeneca tie-up

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) shares jumped 30% following the announcement of a strategic partnership with AstraZeneca PLC (LSE:AZN) that aims to advance...…

ANGLE partners with AstraZeneca in groundbreaking oncology contract

…

AstraZeneca: What The Markets Missing

…

Liquid biopsy firm Angle signs new commercial agreement with AstraZeneca

…

ANGLE inks AstraZeneca deal to develop ground-breaking cancer assay

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of liquid biopsy technologies, has partnered with AstraZeneca PLC (LSE:AZN) to enhance cancer drug...…

AstraZeneca (AZN) to Report Q1 Earnings: Heres What to Expect

Sales of AstraZenecas (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new…

Verhaltene Kauflaune bei Aktie von AstraZeneca plc (64,2491 €)

Wenig Kursbewegung aktuell bei dem Anteilsschein von AstraZeneca plc . Die Aktie notiert derzeit bei 68,39 US-Dollar. Kaum auffällig ist…

AstraZeneca PLCs (LON:AZN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

AstraZeneca (LON:AZN) has had a great run on the share market with its stock up by a significant 7.5% over…

Was AstraZeneca boss Soriot’s pay rise controversial? Not particularly

It was framed as a pitched battle between two opposing camps in AstraZeneca PLC (LSE:AZN)’s shareholder base. On one side,…

Friday papers: Amazon primed to hit $2tn stock market value

And AstraZeneca chief’s pay rise approved despite shareholder revolt.…

Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News

J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZenecas (AZN) Enhertu for metastatic HER2-positive solid tumors.…

AstraZenecas (AZN) Fasenra Gets FDA Nod for Asthma in Kids

The FDA approves AstraZenecas (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11…

AstraZeneca Shareholders Vote in Favor of £19 Million CEO Pay

AstraZeneca Plc shareholders backed a pay increase for Pascal Soriot, who is already the highest paid chief executive officer of…

AstraZeneca shareholders approve 2024 pay policy in boost to CEO Soriot By Reuters

AstraZeneca shareholders approve 2024 pay policy in boost to CEO Soriot…

Result of AGM

11 April 2024 1730 BST Results of Annual General Meeting held on 11 April 2024 AstraZeneca PLC announced the results of the…

AstraZeneca to boost annual dividend by 7%

…

AstraZeneca unveils dividend hike ahead of CEO pay vote at AGM By Reuters

AstraZeneca unveils dividend hike ahead of CEO pay vote at AGM…

AstraZeneca increases 2024 dividend by 7%

11 April 2024 AstraZeneca increases 2024 dividend by 7% AstraZeneca announced today that the Board intends to increase the annualised dividend for…

Ihre wichtigsten Termine: Heute im Blick: AstraZeneca, Frosta, Givaudan, VAT, Gerresheimer, Adecco & Emmi

AstraZeneca pay debate exposes disparity in US-UK corporate values

Tomorrow’s shareholder vote on AstraZeneca PLC (LSE:AZN) boss Pascal Soriot’s compensation represents a microcosm of the broader debate around executive...…

AstraZeneca pay debate exposes disparity in US-UK corporate values

Tomorrow’s shareholder vote on AstraZeneca PLC (LSE:AZN) boss Pascal Soriot’s compensation represents a microcosm of the broader debate around executive...…

BARCLAYS stuft ASTRAZENECA auf Overweight

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Astrazeneca auf "Overweight" mit einem Kursziel von 12500…

Krank nach Corona-Impfung - Astrazeneca zu Auskunft verurteilt

BAMBERG (dpa-AFX) - Im Prozess um einen mutmaßlichen Corona-Impfschaden hat eine Frau aus Oberfranken einen Teilerfolg gegen den Hersteller Astrazeneca…

Enhertu approved in US for HER2+ solid tumours

08 April 2024 Enhertu approved in the US as first tumour-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumours Based on…

AstraZenecas (AZN) Enhertu Gets FDA Nod for Solid Tumors

FDA approves AstraZeneca (AZN) and partner Daiichi Sankyos Enhertu for HER2-expressing metastatic cancers based on data from three phase II…

dpa-AFX ProFeed